5 December 2016

Rentokil Initial is privileged to be part of the assessment amongst UK biggest businesses to achieve rank 25th out of 241 entries from a reputable massive leap from 158.

As the highest riser in 2016, entries are evaluated across 12 criteria, including management quality, financial soundness and service quality, talent development and retention, long term investment value, innovation, marketing capabilities, community and environmentally responsible, corporate assets utilisation, inspirational leadership, company competiveness and corporate governance.

The accolade is a testament as the leader to innovate and staying ahead of competition, to Protecting People, Enhancing lives and benchmarks ourselves above re-owned pharmaceutical giants including GlaxoSmithKline, Pfizer, AstraZeneca and leading financial institutions such as HSBC, Prudential, London Stock Exchange and Shroders.